Jim Schoeneck

Track

Insider profile

Currently holds a position at FibroGen Inc

Performance

Overall performance
3.1
Performance over holding periods
3.1
30 days 90 days 120 days
Average return 12% 8.2% 15.1%
Success rate 53% 68% 82%
Transactions
3 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Chairman of the Board FibroGen Inc Feb. 13, 2020 -
Chairman of the Board, Interim President FibroGen Inc Jan. 6, 2020 - Feb. 13, 2020
Interim Chief Executive Officer, Director FibroGen Inc Aug. 26, 2019 - Jan. 6, 2020
Independent Director FibroGen Inc April 1, 2010 - Aug. 26, 2019
Independent Director AnaptysBio Inc Nov. 1, 2015 - March 20, 2018
Jim Schoeneck's trades of Calidi Biotherapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
US FibroGen Inc (FGEN)
Transaction date
Purchase
Price
349.78
Quantity 9,356 -8.1%
Value US$1,829,287
US FibroGen Inc (FGEN)
Transaction date
Purchase
Price
165.59
Quantity 11,851 +15.6%
Value US$3,445,694
US FibroGen Inc (FGEN)
Transaction date
Purchase
Price
0.35
Quantity 250,000 +339.1%
Value US$88,000
US FibroGen Inc (FGEN)
Transaction date
Planned sale
Price
18.03
Quantity 7,100 -8.8%
Value US$127,987
US FibroGen Inc (FGEN)
Transaction date
Proposed sale
Price
18.03
Quantity 7,100
Value US$127,987
US FibroGen Inc (FGEN)
Transaction date
Planned sale
Price
47.69
Quantity 500 -11.9%
Value US$23,845
US FibroGen Inc (FGEN)
Transaction date
Planned sale
Price
46.80
Quantity 1,500 -26.3%
Value US$70,200
US FibroGen Inc (FGEN)
Transaction date
Planned sale
Price
52.90
Quantity 2,000 -6.7%
Value US$105,800
US FibroGen Inc (FGEN)
Transaction date
Planned sale
Price
55.23
Quantity 380 -1.4%
Value US$20,987
US FibroGen Inc (FGEN)
Transaction date
Planned sale
Price
54.62
Quantity 1,620 -5.5%
Value US$88,484
US FibroGen Inc (FGEN)
Transaction date
Planned sale
Price
57.17
Quantity 2,000 -6.7%
Value US$114,340
US FibroGen Inc (FGEN)
Transaction date
Planned sale
Price
45.90
Quantity 2,000 -6.7%
Value US$91,800
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-08-25 2025-08-21
B Purchase
22,015 +22.8%
266.47
US$3,320,299 		22,015 +22.8% 266.47 US$3,320,299
2025-07-02 2025-06-30
US FibroGen Inc (FGEN)
B Purchase
9,356 -8.1%
349.78
US$1,829,287 		9,356 -8.1% 349.78 US$1,829,287
2025-03-24 2025-03-21
US FibroGen Inc (FGEN)
B Purchase
11,851 +15.6%
165.59
US$3,445,694 		11,851 +15.6% 165.59 US$3,445,694
2025-03-24 2025-03-20
US FibroGen Inc (FGEN)
B Purchase
250,000 +339.1%
0.35
US$88,000 		250,000 +339.1% 0.35 US$88,000
2023-06-09 2023-06-07
US FibroGen Inc (FGEN)
PlS Planned sale
7,100 -8.8%
18.03
US$127,987 		7,100 -8.8% 18.03 US$127,987
2023-06-07 2023-06-07
US FibroGen Inc (FGEN)
PrS Proposed sale
7,100
18.03
US$127,987 		7,100 18.03 US$127,987
2019-05-09 2019-05-07
US FibroGen Inc (FGEN)
PlS Planned sale
500 -11.9%
47.69
US$23,845 		500 -11.9% 47.69 US$23,845
2019-05-09 2019-05-07
US FibroGen Inc (FGEN)
PlS Planned sale
1,500 -26.3%
46.80
US$70,200 		1,500 -26.3% 46.80 US$70,200
2019-04-10 2019-04-08
US FibroGen Inc (FGEN)
PlS Planned sale
2,000 -6.7%
52.90
US$105,800 		2,000 -6.7% 52.90 US$105,800
2019-03-08 2019-03-07
US FibroGen Inc (FGEN)
PlS Planned sale
380 -1.4%
55.23
US$20,987 		380 -1.4% 55.23 US$20,987
2019-03-08 2019-03-07
US FibroGen Inc (FGEN)
PlS Planned sale
1,620 -5.5%
54.62
US$88,484 		1,620 -5.5% 54.62 US$88,484
2019-02-08 2019-02-07
US FibroGen Inc (FGEN)
PlS Planned sale
2,000 -6.7%
57.17
US$114,340 		2,000 -6.7% 57.17 US$114,340
2019-01-09 2019-01-07
US FibroGen Inc (FGEN)
PlS Planned sale
2,000 -6.7%
45.90
US$91,800 		2,000 -6.7% 45.90 US$91,800